-+ 0.00%
-+ 0.00%
-+ 0.00%

ASTRAZENECA - IMFINZI PLUS TARLATAMAB SAFETY PROFILE CONSISTENT WITH INDIVIDUAL TREATMENTS, NO NEW SAFETY SIGNALS

Reuters·09/08/2026 13:02:26